Lightweight Felipe Olivieri has been flagged for a potential violation of the UFC and USADA anti-doping policy stemming from an out of competition test prior to his UFC debut bout in January.
The UFC released a statement regarding the potential violation, saying Oliveira passed a drug test the night of his loss to Tony Martin at UFC on Fox 18, with the violation coming from a test in the lead up to the fight.
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Felipe Olivieri of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection. Although the sample collected from Olivieri following his bout at UFC Fight Night: Johnson vs. Bader on January 30, 2016, was reported as negative for prohibited substances, a sample collected from him in Brazil earlier that month, and analyzed at the WADA accredited laboratory in Rio de Janeiro, was recently reported to USADA as containing a prohibited substance.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Olivieri, as it relates to the UFC Anti-Doping Policy and future UFC participation. Because Olivieri participated in a bout sanctioned by the New Jersey State Athletic Control Board after the sample in question was collected, USADA will work to ensure that the Board has the necessary information to determine the appropriate course of action under the Board’s rules.
Oliveiri’s submission loss to Martin on that card snapped a three fight winning streak. He faces up to a two year suspension from USADA, along with additional punishment from the NJSACB.
Attention iPhone/iPad and Android users, if you’ve enjoyed our app in the past and followed us there, or if you’ve never checked it out, make sure to update to the latest version in the Apple store and/or Google Play store. We’ve launched a new look for the app, in line with our recent desktop overhaul. Make sure to check it out!
For current App users, swipe right to view next article, swipe left to view previous article.